参考文献/References:
[1]Ammirati AL.Chronic Kidney Disease[J].Rev Assoc Med Bras (1992),2020,66Suppl 1(Suppl 1):s03-s09.[2]Zarantonello D,Rhee CM,Kalantar-Zadeh K,et al.Novel conservative management of chronic kidney disease via dialysis-free interventions[J].Curr Opin Nephrol Hypertens,2021,30(1):97-107.[3]GBD Chronic Kidney Disease Collaboration.Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2020,395(10225):709-733.[4]Zhuang Z,Tong M,Clarke R,et al.Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey[J].Clin Kidney J,2022,15(12):2228-2236.[5]Kalantar-Zadeh K,Li PK,Tantisattamo E,et al.Living well with kidney disease by patient and care-partner empowerment: Kidney health for everyone everywhere[J].Patient Educ Couns,2022,105(1):243-245.[6]Schmidt TSB,Raes J,Bork P.The Human Gut Microbiome: From Association to Modulation[J].Cell,2018,172(6):1198-1215.[7]Witkowski M,Weeks TL,Hazen SL.Gut Microbiota and Cardiovascular Disease[J].Circ Res,2020,127(4):553-570.[8]Cammarota G,Ianiro G,Ahern A,et al.Gut microbiome, big data and machine learning to promote precision medicine for cancer[J].Nat Rev Gastroenterol Hepatol,2020,17(10):635-648.[9]Radjabzadeh D,Bosch JA,Uitterlinden AG,et al.Gut microbiome-wide association study of depressive symptoms[J].Nat Commun,2022,13(1):7128.[10]Vaziri ND,Wong J,Pahl M,et al.Chronic kidney disease alters intestinal microbial flora[J].Kidney Int,2013,83(2):308-315.[11]Yang T,Richards EM,Pepine CJ,et al.The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease[J].Nat Rev Nephrol,2018,14(7):442-456.[12]Huang Y,Xin W,Xiong J,et al.The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease[J].Front Pharmacol,2022,13:837500.[13]Evenepoel P,Poesen R,Meijers B.The gut-kidney axis[J].Pediatr Nephrol,2017,32(11):2005-2014.[14]O’Donnell JA,Zheng T,Meric G,et al.The gut microbiome and hypertension[J].Nat Rev Nephrol,2023,19(3):153-167.[15]Bj?觟rkegren JLM,Lusis AJ.Atherosclerosis: Recent developments[J].Cell,2022,185(10):1630-1645.[16]Joossens M,Faust K,Gryp T,et al.Gut microbiota dynamics and uraemic toxins: one size does not fit all[J].Gut,2019,68(12):2257-2260.[17]Hobby GP,Karaduta O,Dusio GF,et al.Chronic kidney disease and the gut microbiome[J].Am J Physiol Renal Physiol,2019,316(6):F1211-F1217.[18]Karakan T,Ozkul C,Küpeli Akkol E,et al.Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders[J].Nutrients,2021,13(2):389.[19]Mishima E,Fukuda S,Mukawa C,et al.Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach[J].Kidney Int,2017,92(3):634-645.[20]Gill SK,Rossi M,Bajka B,et al.Dietary fibre in gastrointestinal health and disease[J].Nat Rev Gastroenterol Hepatol,2021,18(2):101-116.[21]Bammens B,Verbeke K,Vanrenterghem Y,et al.Evidence for impaired assimilation of protein in chronic renal failure[J].Kidney Int,2003,64(6):2196-2203.[22]Andersen K,Kesper MS,Marschner JA,et al.Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation[J].J Am Soc Nephrol,2017,28(1):76-83.[23]Wong J,Piceno YM,DeSantis TZ,et al.Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD[J].Am J Nephrol,2014,39(3):230-237.[24]Meijers B,Evenepoel P,Anders HJ.Intestinal microbiome and fitness in kidney disease[J].Nat Rev Nephrol,2019,15(9):531-545.[25]Sun X,Liu Y.Matrix Metalloproteinase-10 in Kidney Injury Repair and Disease[J].Int J Mol Sci,2022,23(4):2131.[26]Fr?諭k W,Kucmierz J,Szlagor M,et al.New Insights into Molecular Mechanisms of Chronic Kidney Disease[J].Biomedicines,2022,10(11):2846.[27]Poesen R,Windey K,Neven E,et al.The Influence of CKD on Colonic Microbial Metabolism[J].J Am Soc Nephrol,2016,27(5):1389-1399.[28]Stavropoulou E,Kantartzi K,Tsigalou C,et al.Focus on the Gut-Kidney Axis in Health and Disease[J].Front Med (Lausanne),2021,7:620102.[29]Tang WH,Wang Z,Levison BS,et al.Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk[J].N Engl J Med,2013,368(17):1575-1584.[30]Caetano-Silva ME,Rund L,Hutchinson NT,et al.Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids[J].Sci Rep,2023,13(1):2819.[31]Ranganathan N,Friedman EA,Tam P,et al.Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada[J].Curr Med Res Opin,2009,25(8):1919-1930.[32]Tayebi Khosroshahi H,Vaziri ND,Abedi B,et al.Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial[J].Hemodial Int,2018,22(4):492-500.[33]Headley SA,Chapman DJ,Germain MJ,et al.The effects of 16-weeks of prebiotic supplementation and aerobic exercise training on inflammatory markers, oxidative stress, uremic toxins, and the microbiota in pre-dialysis kidney patients: a randomized controlled trial-protocol paper[J].BMC Nephrol,2020,21(1):517.
相似文献/References:
[1]谢 琴.肾小球C4d沉积在慢性肾病早期诊断及预后的价值分析[J].医学信息,2018,31(08):81.[doi:10.3969/j.issn.1006-1959.2018.08.025]
XIE Qin.Value of Glomerular C4d Deposition in Early Diagnosis and Prognosis of Chronic Kidney Disease[J].Journal of Medical Information,2018,31(03):81.[doi:10.3969/j.issn.1006-1959.2018.08.025]
[2]韦能宝,薛志刚,毕金文.尿源性脓毒血症诊治分析[J].医学信息,2018,31(24):170.[doi:10.3969/j.issn.1006-1959.2018.24.052]
WEI Neng-bao,XUE Zhi-gang,BI Jin-wen.Diagnosis and Treatment of Urinary Sepsis[J].Journal of Medical Information,2018,31(03):170.[doi:10.3969/j.issn.1006-1959.2018.24.052]
[3]彭琪彦.慢性肾脏病患者RBP与T淋巴细胞亚群
检测的临床意义[J].医学信息,2019,32(18):91.[doi:10.3969/j.issn.1006-1959.2019.18.029]
PENG Qi-yan.Clinical Significance of Detection of RBP and T Lymphocyte Subsets in
Patients with Chronic Kidney Disease[J].Journal of Medical Information,2019,32(03):91.[doi:10.3969/j.issn.1006-1959.2019.18.029]
[4]崔方强.足细胞上皮间质转分化研究[J].医学信息,2019,32(22):21.[doi:10.3969/j.issn.1006-1959.2019.22.008]
CUI Fang-qiang.Epithelial Transdifferentiation of Podocytes[J].Journal of Medical Information,2019,32(03):21.[doi:10.3969/j.issn.1006-1959.2019.22.008]
[5]高 彬,孙 娜,常文秀.慢性肾脏病患者血钾异常相关因素分析[J].医学信息,2019,32(22):91.[doi:10.3969/j.issn.1006-1959.2019.22.027]
GAO Bin,SUN Na,CHANG Wen-xiu.Analysis of Related Factors of Serum Potassium Abnormality in Patients with Chronic Kidney Disease[J].Journal of Medical Information,2019,32(03):91.[doi:10.3969/j.issn.1006-1959.2019.22.027]
[6]袁 娟,赫英龙.参芎葡萄糖与前列地尔治疗慢性肾脏病的疗效比较[J].医学信息,2020,33(14):163.[doi:10.3969/j.issn.1006-1959.2020.14.053]
YUAN Juan,HE Ying-long.Comparison of Curative Effect between Shenqiong Glucose and Alprostadil in Treating Chronic Kidney Disease[J].Journal of Medical Information,2020,33(03):163.[doi:10.3969/j.issn.1006-1959.2020.14.053]
[7]叶廷巧,赵 亮,庾 辉,等.托伐普坦治疗心力衰竭合并肾功能不全的研究[J].医学信息,2020,33(15):69.[doi:10.3969/j.issn.1006-1959.2020.15.022]
YE Ting-qiao,ZHAO Liang,YU Hui,et al.Tolvaptan in the Treatment of Heart Failure with Renal Insufficiency[J].Journal of Medical Information,2020,33(03):69.[doi:10.3969/j.issn.1006-1959.2020.15.022]
[8]倪 曼.非布司他与别嘌醇治疗慢性肾脏病合并高尿酸血症的疗效比较[J].医学信息,2020,33(15):140.[doi:10.3969/j.issn.1006-1959.2020.15.043]
NI Man.Comparison of the Efficacy of Febuxostat Tablets and Allopurinol in the Treatment of Chronic Kidney Disease with Hyperuricemia[J].Journal of Medical Information,2020,33(03):140.[doi:10.3969/j.issn.1006-1959.2020.15.043]
[9]王希敏.2型糖尿病并发慢性肾脏病患者外周血T淋巴细胞亚群变化与肾血管内皮功能障碍的相关 分析[J].医学信息,2021,34(23):77.[doi:10.3969/j.issn.1006-1959.2021.23.021]
WANG Xi-min.Correlation Analysis of T Lymphocyte Subsets in Peripheral Blood with Renal Vascular Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus Complicated with Chronic Kidney Disease[J].Journal of Medical Information,2021,34(03):77.[doi:10.3969/j.issn.1006-1959.2021.23.021]
[10]刘瑞尔,严琴琴,吴 江,等.高尿酸血症对慢性肾脏病及合并症影响的研究进展[J].医学信息,2022,35(07):45.[doi:10.3969/j.issn.1006-1959.2022.07.012]
LIU Rui-er,YAN Qin-qin,WU Jiang,et al.Research Progress of Hyperuricemia on Chronic Kidney Disease and Complications[J].Journal of Medical Information,2022,35(03):45.[doi:10.3969/j.issn.1006-1959.2022.07.012]